Chronic Lymphocytic Leukemia

>

The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy.

Latest News

Alvaro J. Alencar, MD
NX-5948 Demonstrates Preliminary Efficacy in High-Risk CLL

February 6th 2025

Alvaro Alencar, MD, discusses the preliminary efficacy and safety of NX-5948, a BTK degrader, in patients with chronic lymphocytic leukemia.

Chronic Lymphocytic Leukemia |Image Credit: © LASZLO – stock.adobe.com
Ibrutinib/Venetoclax Combo Demonstrates Sustained TEAE-Free PFS in First-Line CLL

January 22nd 2025

Chronic Lymphocytic Leukemia | stock.adobe.com
Zanubrutinib Plus Obinutuzumab/Venetoclax Associated With Durable uMRD4 Outcomes in Treatment-Naive CLL

January 13th 2025

Supriya Gupta, MD
Venetoclax Plus BTK Inhibitor–Based Combinations Represent Promising Avenue in CLL/SLL

January 9th 2025

Duvelisib Plus Venetoclax in Chronic Lymphocytic Leukemia | Image Credit: © LASZLO– stock.adobe.com
Duvelisib Plus Venetoclax Is Active in Relapsed/Refractory CLL and Richter Syndrome

January 9th 2025

More News